Federal Circuit Rules For Pfizer In Teva's Challenge To Zoloft Patent

Law360, New York (January 23, 2005, 12:00 AM EST) -- In a closely watched test of key provisions of the Hatch-Waxman Act, the U.S. Court of Appeals for the Federal Circuit has ruled for Pfizer in a lawsuit brought by Israeli generic manufacturer Teva Pharmaceuticals that challenged the patent for the antidepressant Zoloft.

Teva Pharmaceutical Industries Ltd. sought to challenge Pfizer's patent on a method of making Zoloft so that the company could begin selling a generic version when the patent protecting the chemical composition of the drug expired in 2006.

The U.S. Court of Appeals...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.